Personal Cfo Solutions, LLC Mereo Biopharma Group PLC Transaction History

Personal Cfo Solutions, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$0.33 - $1.69 $8,543 - $43,750	-25,888 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$1.51 - $2.59 $11,325 - $19,425	-7,500 Reduced 22.46%	25,888 $41,000
Q2 2021 Jul 22, 2021	SELL	$2.94 - $4.08 $121,680 - $168,863	-41,388 Reduced 55.35%	33,388 $106,000
Q1 2021 Apr 21, 2021	BUY	$2.6 - $4.43 $194,417 - $331,257	74,776 New	74,776 $252,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $419M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.